Antidote's funding news was covered in Biospectrum Asia this week. The article explains:
"Antidote Technologies, a clinical trial matching platform, has raised £11m in a funding round led by Merck Global Health Innovation Fund (GHI) and joined by existing investors Smedvig Capital and Octopus Ventures.
Helping patients find medical trials online, the start-up has made 14,000 ‘matches’ to date, and plans to reach full coverage of US trials next year with added features, such as matching cancer patients to studies using mutation-level data."
Read more at Biospectrum Asia.
